This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TSC Ratings Update: 'Hold' Healthways

-- Rising expenses and debt. The cost of services increased 3.9% to $129.05 million from $124.19 million while selling, general and administrative expenses edged up 6.5% to $17.95 million from $16.85 million. Furthermore, total debt for the quarter spiked 6.4% to $307.10 million from $288.72 million deteriorating the debt-to-equity ratio to 0.84 from 0.75.


Healthways Inc.'s Q1 FY09 revenue grew 5.5% to $185.40 million from $175.82 million in the prior year's quarter due to contributions from the commencement of new contracts, increase in the recognition of performance-based fees and growth in the number of self-insured employers on behalf of its health plan customers. Geographically, international revenue totaled $3.80 million and domestic revenue totaled $181.60 million. Moreover, domestic commercial available lives increased 6.3% to 195.00 million from 183.40 million while domestic commercial billed lives advanced 22.5% to 32.70 million from 26.70 million in Q1 FY08 attributed to signing of new contracts, expansion or extension of contracts with health plans and employers. Furthermore, the annualized revenue in backlog stood at $31.90 million compared to $51.00 million a year ago.

During the quarter, gross profit margin widened 103 basis points to 30.40% from 29.37% a year ago despite a 3.9% increase in cost of services. Cost of services stood at $129.05 million compared to $124.19 million. Selling, general, and administrative expenses edged up 6.5% to $17.95 million from $16.85 million. Operating margin increased 31 basis points to 14.15% from 13.84%. Interest expenses declined 4.5% to $5.10 million from $5.34 million there by improving the interest coverage ratio to 5.15 from 4.55 a year ago. Finally, net income for the quarter swelled 12.5% to $12.58 million or $0.37 per share compared to $11.18 million or $0.30 per share in the prior year's quarter attributed to higher revenue.
2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HWAY $11.81 -1.75%
AAPL $93.24 -0.41%
FB $117.81 -0.21%
GOOG $701.43 0.82%
TSLA $211.53 -4.96%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs